Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Earliest Stage Treatment of Actinic Keratosis with Imiquimod 3.75% Cream:
The study is to demonstrate that Aktinic Keratosis are present before they are clinically
visible, i.e. in a subclinical stage. Since on the basis of the research situation, also
subclinical AK can proliferate into the dermis, it is possible that with the application of
Imiquimod on chronically light-exposed skin, undetected squamous cell carcinoma can be
recognized and treated at the same time.